The Food and Drugs Act has elements in it that allow you to charge fees, but it's not a comprehensive instrument to do that. What we're doing is modifying it slightly to allow us to have a more robust fee-setting instrument and then to go and charge fees.
On May 9th, 2017. See this statement in context.